Xilio Therapeutics Inc (XLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 43,766 | 6,344 | 0 | 0 | 0 |
| Gross Profit | 43,766 | 6,344 | N/A | N/A | N/A |
| Operating Expenses | 85,748 | 66,926 | 79,133 | 89,149 | 75,044 |
| Operating Income | -41,982 | -60,582 | -79,133 | -89,149 | -75,044 |
| Other Income | 6,946 | 2,341 | 2,729 | 927 | -756 |
| Pre-tax Income | -35,036 | -58,241 | -76,404 | -88,222 | -75,800 |
| Net Income Continuous | -35,036 | -58,241 | -76,404 | -88,222 | -75,800 |
| Net Income | $-35,036 | $-58,241 | $-76,404 | $-88,222 | $-75,800 |
| EPS Basic Total Ops | -4.19 | -15.24 | -38.94 | -45.10 | -189.36 |
| EPS Basic Continuous Ops | -4.19 | -15.24 | -38.92 | -45.11 | -189.36 |
| EPS Diluted Total Ops | -4.19 | -15.24 | -38.94 | -45.10 | -189.36 |
| EPS Diluted Continuous Ops | -4.19 | -15.24 | -38.92 | -45.11 | -189.36 |
| EPS Diluted Before Non-Recurring Items | -4.89 | -15.27 | -38.94 | -45.10 | -189.36 |
| EBITDA(a) | $-40,441 | $-58,938 | $-77,233 | $-87,302 | $-73,545 |